Tandem Diabetes Care CEO Kim Blickenstaff's 2018 pay jumps 298% to $3M
Tandem Diabetes Care reports 2018 executive compensation
By ExecPay News
Published: April 11, 2019
Tandem Diabetes Care reported fiscal year 2018 executive compensation information on April 11, 2019.
In 2018, five executives at Tandem Diabetes Care received on average a compensation package of $2.1M, a 224% increase compared to previous year.
Average pay of disclosed executives at Tandem Diabetes Care
Kim D. Blickenstaff, Chief Executive Officer, received $3M in total, which increased by 298% compared to 2017. 80% of Blickenstaff's compensation, or $2.4M, was in option awards. Blickenstaff also received $583K in non-equity incentive plan, $1 in salary, as well as $4.9K in other compensation.
For fiscal year 2018, the median employee pay was $142,953 at Tandem Diabetes Care. Therefore, the ratio of Kim D. Blickenstaff's pay to the median employee pay was 21 to one.
John F. Sheridan, Chief Executive Officer, received a compensation package of $1.9M, which increased by 224% compared to previous year. 62% of the compensation package, or $1.2M, was in option awards.
Brian B. Hansen, Executive Vice President and Chief Commercial Officer, earned $1.9M in 2018, a 218% increase compared to previous year.
David B. Berger, General Counsel, received $1.9M in 2018.
Leigh A. Vosseller, Chief Financial Officer, earned $1.9M in 2018.
Related executives
Kim Blickenstaff
Tandem Diabetes Care
Chief Executive Officer
John Sheridan
Tandem Diabetes Care
Chief Executive Officer
Leigh Vosseller
Tandem Diabetes Care
Chief Financial Officer
David Berger
Tandem Diabetes Care
Chief Operating Officer
Brian Hansen
Tandem Diabetes Care
Executive Vice President, Chief Commercial Officer
You may also like
Source: SEC filing on April 11, 2019.